Henry Schein (NASDAQ:HSIC) Posts Earnings Results, Misses Estimates By $0.04 EPS

Henry Schein (NASDAQ:HSIC) posted its earnings results on Tuesday. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04), Zacks reports. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein updated its FY 2025 guidance to 4.800-4.940 EPS.

Henry Schein Trading Up 0.5 %

Shares of HSIC opened at $77.64 on Tuesday. The stock’s 50-day moving average price is $74.19 and its 200 day moving average price is $72.38. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $9.68 billion, a price-to-earnings ratio of 31.95, a P/E/G ratio of 2.13 and a beta of 0.91. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Wells Fargo & Company began coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Finally, Barrington Research boosted their price objective on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Eight equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $80.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.